Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).

about

Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).

Item

http://www.wikidata.org/entity/Q43794676

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Outcome of pediatric acute lym ...... 's Cancer Study Group (TCCSG).

@en

Outcome of pediatric acute lym ...... Children's Cancer Study Group

@nl

type

Item

label

Outcome of pediatric acute lym ...... 's Cancer Study Group (TCCSG).

@en

Outcome of pediatric acute lym ...... Children's Cancer Study Group

@nl

prefLabel

Outcome of pediatric acute lym ...... 's Cancer Study Group (TCCSG).

@en

Outcome of pediatric acute lym ...... Children's Cancer Study Group

@nl

P1476

Outcome of pediatric acute lym ...... 's Cancer Study Group (TCCSG).

@en

P2093

Akiko M Saito

http://www.w3.org/2001/XMLSchema#string

Akira Ohara

http://www.w3.org/2001/XMLSchema#string

Atsushi Manabe

http://www.w3.org/2001/XMLSchema#string

Chitose Ogawa

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Goto

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Koh

http://www.w3.org/2001/XMLSchema#string

Masahiro Tsuchida

http://www.w3.org/2001/XMLSchema#string

Takeshi Inukai

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.

A revised definition for cure of childhood acute lymphoblastic leukemia.

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.

Relapsed childhood acute lymphoblastic leukaemia.

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

P2888

s12185-014-1710-z

P304

52-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-014-1710-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Motohiro Kato

P577

2014-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25432437

http://www.w3.org/2001/XMLSchema#string

P921

leukemia